Target of rapamycin complex 2 subunit MAPKAP1 (MAPKAP1)

Target of rapamycin complex 2 subunit MAPKAP1 (MAPKAP1, commonly known as SIN1) is an essential scaffold and substrate adaptor protein within the mTORC2 complex, a key component of signaling pathways governing cell growth, survival, metabolism, cytoskeletal remodeling, and stress responses. MAPKAP1 is necessary for substrate recognition (especially AGC family kinases like AKT, PKC, and SGK1) and regulates downstream phosphorylation events critical for cell proliferation, migration, and differentiation. Its overexpression has been linked to the development and progression of numerous cancers, and it coordinates signals intersecting with oncogenic pathways such as Hippo, WNT, Notch, and MAPK. As part of mTORC2, MAPKAP1’s activity is distinct from mTORC1 and is mainly regulated independently of nutrient signals. Therapeutically, MAPKAP1 is targeted indirectly by mTOR inhibitors, though adverse feedback and pathway redundancy present ongoing challenges for clinical applications[1][2][4][5].

Other names

MAPKAP1SIN1mSIN1MIP1Mitogen-activated protein kinase 2-associated protein 1Mitogen-activated protein kinase associated protein 1Stress-activated protein kinase-interacting 1SAPK-interacting protein 1TORC2 subunit MAPKAP1JC310MEKK2-interacting protein 1

Drugs that inhibit **mTORC2** (and mTOR complexes more generally) suppress MAPKAP1’s kinase-mediated adaptations, including: - **Inhibition of downstream AGC kinase activation** (AKT, PKC, SGK1) - **Disruption of cell proliferation and survival pathways** - **Blockade of cytoskeletal regulation and lipogenesis**[4]